BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12629989)

  • 1. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
    Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
    Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
    Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
    J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
    Bedossa P; Peltier E; Terris B; Franco D; Poynard T
    Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
    Lu Y; Wu LQ; Li CS; Wang SG; Han B
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma.
    Ito N; Kawata S; Tamura S; Takaishi K; Shirai Y; Kiso S; Yabuuchi I; Matsuda Y; Nishioka M; Tarui S
    Cancer Res; 1991 Aug; 51(15):4080-3. PubMed ID: 1649698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
    Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
    Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
    Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
    Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor beta isoforms and their receptors in malignant fibrous histiocytoma of soft tissues.
    Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Nakatani T; Kurosaka M
    Clin Cancer Res; 2004 Sep; 10(17):5804-7. PubMed ID: 15355909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
    Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
    Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 in human liver tumors.
    Vogelbruch M; Wellmann A; Maschek H; Schäfer MK; Flemming P; Georgii A
    Verh Dtsch Ges Pathol; 1995; 79():132-6. PubMed ID: 8600677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H; Sauer U; Schleicher E; Nerlich A
    Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.